Zobrazeno 1 - 10
of 1 430
pro vyhledávání: '"Shiu, KK."'
Autor:
Formica, V. *, Morelli, C., Patrikidou, A., Shiu, KK., Nardecchia, A., Lucchetti, J., Roselli, M., Arkenau, HT.
Publikováno v:
In Critical Reviews in Oncology / Hematology January 2021 157
Autor:
Lordick F; Department of Medicine (Oncology, Gastroenterology, Hepatology, Pulmonology), University of Leipzig Medical Center, Comprehensive Cancer Center Central Germany (CCCG), Leipzig, Germany. Electronic address: florian.lordick@medizin.uni-leipzig.de., Mauer ME; European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium., Stocker G; Department of Medicine (Oncology, Gastroenterology, Hepatology, Pulmonology), University of Leipzig Medical Center, Comprehensive Cancer Center Central Germany (CCCG), Leipzig, Germany., Cella CA; Istituto Europeo di Oncologia, IRCCS, Milano, Italy., Ben-Aharon I; Rambam Health Care Campus, Department of Oncology, Haifa, Israel., Piessen G; CHRU de Lille - Hôpital Huriez, Lille, France., Wyrwicz L; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Al-Haidari G; Oslo University Hospital - Ullevaal Hospital, Oslo, Norway., Fleitas-Kanonnikoff T; Hospital Clinico Universitario De Valencia, Incliva Biomedical Research Institute, Valencia, Spain., Boige V; Department of Cancer Medicine, Institut Gustave Roussy, Villejuif, France., Obermannová RL; Department of Comprehensive Cancer Care Masaryk Memorial Cancer Institute and Faculty of Medicine, Masaryk University Brno, Czech Republic., Martens UM; Department of Oncology, SLK-Kliniken Heilbronn, Heilbronn, Germany., Gomez-Martin C; Hospital Universitario 12 De Octubre, Madrid, Spain., Thuss-Patience P; Charite - Universitaetsmedizin Berlin - Campus Virchow-Klinikum, Berlin, Germany., Arrazubi V; Hospital Universitario de Navarra, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain., Avallone A; Istituto Nazionale Tumori- IRCCS - Fondazione G. Pascale, Napoli, Italy., Shiu KK; University College Hospital, London, United Kingdom., Artru P; Hôpital Privé Jean Mermoz, Lyon, France., Brenner B; Rabin Medical Center, Beilinson Hospital, Petach Tikva, and Tel-Aviv University, Ramat Aviv, Tel-Aviv, Israel., Sanchez CB; Department of Medical Oncology. ICO- Badalona (Catalan Institute of Oncology - Badalona), Barcelona, Spain., Chau I; Royal Marsden Hospital, London & Surrey, United Kingdom., Lorenzen S; Department of Haematology and Oncology, Klinikum rechts der Isar, Technische Universitaet Muenchen, Munich, Germany., Daum S; Charite - Universitaetsmedizin Berlin - Campus Benjamin-Franklin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Gastroenterology, Infectious Diseases and Rheumatology, Berlin, Germany., Sinn M; University Medical Center Hamburg-Eppendorf, Center of Oncology, Hamburg, Germany., Merelli B; Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy., van Grieken NCT; Department of Pathology, Amsterdam UMC location VUmc-Amsterdam, VU University, Amsterdam; Cancer Center Amsterdam, Amsterdam, The Netherlands., Nilsson M; Division of Surgery and Oncology, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet and Department of Upper Abdominal Diseases, Karolinska University Hospital, Stockholm, Sweden., Collienne M; European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium., Giraut A; European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium., Smyth E; Oxford NIHR Biomedical Research Centre, Churchill Hospital, Oxford, UK.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2024 Nov 12. Date of Electronic Publication: 2024 Nov 12.
Autor:
Platt JR; Division of Oncology, Leeds Institute of Medical Research at St James's, University of Leeds, Leeds. Electronic address: j.r.platt@leeds.ac.uk., Allotey J; Department of Oncology, Aberdeen Royal Infirmary, NHS Grampian, Aberdeen, UK., Alouani E; Digestive Oncology Department, Rangueil Hospital, University Hospital of Toulouse, Toulouse, France., Glasbey J; Institute of Applied Health Research, University of Birmingham, Birmingham, UK. Electronic address: https://twitter.com/DrJamesGlasbey., Intini R; Medical Oncology 1, Veneto Institute of Oncology IOV-IRCCS, Padua., Lonardi S; Medical Oncology 3, Veneto Institute of Oncology IOV-IRCCS, Padua., Mazzoli G; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Militello AM; Department of Oncology, University College London Hospitals NHS Foundation Trust, London, UK., Modest DP; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin; German Cancer Consortium (DKTK), German Cancer Research Centre (DKFZ), Heidelberg, Germany., Palle J; Université Paris Cité, Digestive Oncology Department, Hôpital Européen Georges Pompidou, Paris; Université Paris Cité, Pancreatology and Digestive Oncology Department, Hôpital Beaujon, Clichy, France., Pietrantonio F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Riyad K; The John Goligher Colorectal Surgery Unit, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Samuel L; Department of Oncology, Aberdeen Royal Infirmary, NHS Grampian, Aberdeen, UK., Schulze AV; Department of Hematology, Oncology and Tumor Immunology, Charité - Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin., Shiu KK; Department of Oncology, University College London Hospitals NHS Foundation Trust, London, UK., Taieb J; Institut du Cancer Paris CARPEM, Gastroenterology and Digestive Oncology Department, APHP Centre - Université Paris Cité, Hôpital Européen Georges Pompidou, Paris, France., Tolan DJM; Department of Radiology, Leeds Teaching Hospitals NHS Trust, Leeds., West NP; Division of Pathology and Data Analytics, Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK., Westwood AC; Division of Pathology and Data Analytics, Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK., Williams CJM; Division of Oncology, Leeds Institute of Medical Research at St James's, University of Leeds, Leeds. Electronic address: https://twitter.com/chrisjmwilliams., Seligmann JF; Division of Oncology, Leeds Institute of Medical Research at St James's, University of Leeds, Leeds.
Publikováno v:
ESMO open [ESMO Open] 2024 Sep; Vol. 9 (9), pp. 103698. Date of Electronic Publication: 2024 Sep 05.
Autor:
Kawazoe A; National Cancer Center Hospital East, Kashiwa, Japan., Xu RH; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangdong, China., García-Alfonso P; Medical Oncology Service, Hospital G. U. Gregorio Marañón, IiSGM, Universidad Complutense, Madrid, Spain., Passhak M; Rambam Health Care Campus-Oncology, Haifa, Israel., Teng HW; Division of Medical Oncology, Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan.; National Yang Ming Chiao Tung University, Hsinchu, Taiwan., Shergill A; University of Chicago Pritzker School of Medicine, Chicago, IL., Gumus M; Istanbul Medeniyet University Hospital, Istanbul, Turkey., Qvortrup C; Righospitalet, Copenhagen, Denmark., Stintzing S; Department of Oncology, Rigshospitalet, Copenhagen, Denmark., Towns K; North York General Hospital, Toronto, ON, Canada., Kim TW; Department of Oncology, Asan Medical Center, University of Ulsan, Seoul, Republic of Korea., Shiu KK; University College Hospital, NHS Foundation Trust, London, United Kingdom., Cundom J; Instituto de Diagnóstico e Investigaciones Metabólicas, Buenos Aires, Argentina., Ananda S; Peter MacCallum Cancer Centre and Epworth Healthcare, Melbourne, VIC, Australia., Lebedinets A; Leningrad Regional Clinical Oncology Dispensary, St Petersburg, Russia., Fu R; MSD China, Shanghai, China., Jain R; Merck & Co, Inc, Rahway, NJ., Adelberg D; Merck & Co, Inc, Rahway, NJ., Heinemann V; Comprehensive Cancer Center at Ludwig Maximilian University of Munich, Munich, Germany., Yoshino T; National Cancer Center Hospital East, Kashiwa, Japan., Elez E; Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Aug 20; Vol. 42 (24), pp. 2918-2927. Date of Electronic Publication: 2024 Jun 04.
Autor:
Krämer A; Clinical Cooperation Unit Molecular Hematology-Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany. Electronic address: a.kraemer@dkfz-heidelberg.de., Bochtler T; Clinical Cooperation Unit Molecular Hematology-Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany; Department of Medical Oncology, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany., Pauli C; Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland; Department of Pathology and Molecular Pathology, University Hospital of Zurich, Zurich, Switzerland; Medical Faculty, University of Zurich, Zurich, Switzerland., Shiu KK; UCLH Gastrointestinal Oncology Service, Cancer of Unknown Primary Service, University College London, Cancer Institute, London, UK., Cook N; The Christie NHS Foundation Trust and Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK., de Menezes JJ; Clinical Oncology, Centro Integrado de Pesquisa em Oncologia, Porto Alegre, Brazil., Pazo-Cid RA; Medical Oncology Department, Miguel Servet University Hospital, Zaragoza, Spain., Losa F; Medical Oncology Department, Hospital de Sant Joan Despí Moisès Broggi, ICO Hospitalet, Barcelona, Spain., Robbrecht DG; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Netherlands., Tomášek J; Masaryk Memorial Cancer Institute, Brno, Czech Republic., Arslan C; Izmir University of Economics Medical Point Hospital, Izmir, Türkiye., Özgüroğlu M; Istanbul University Cerrahpasa, Cerrahpasa Faculty of Medicine, Department of Internal Medicine, Division of Oncology, Istanbul, Türkiye., Stahl M; Evang Kliniken Essen-Mitte, Essen, Germany., Bigot F; Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Angers, France., Kim SY; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea., Naito Y; Department of General Internal Medicine, National Cancer Center Hospital East, Kashiwa, Japan., Italiano A; Institut Bergonie, Early Phase Trials and Sarcoma Units, Bordeaux, France., Chalabi N; Global Product Development Medical Affairs, F Hoffmann-La Roche, Basel, Switzerland., Durán-Pacheco G; Global Product Development Medical Affairs, F Hoffmann-La Roche, Basel, Switzerland., Michaud C; Global Product Development Medical Affairs, F Hoffmann-La Roche, Basel, Switzerland., Scarato J; Global Product Development Medical Affairs, F Hoffmann-La Roche, Basel, Switzerland., Thomas M; Global Product Development Medical Affairs, F Hoffmann-La Roche, Basel, Switzerland., Ross JS; Pathology Group, Foundation Medicine, Cambridge, MA, USA; Upstate Medical University Departments of Pathology, Urology and Medicine (Oncology), Syracuse, NY, USA., Moch H; Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland; Department of Pathology and Molecular Pathology, University Hospital of Zurich, Zurich, Switzerland; Medical Faculty, University of Zurich, Zurich, Switzerland., Mileshkin L; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
Publikováno v:
Lancet (London, England) [Lancet] 2024 Aug 10; Vol. 404 (10452), pp. 527-539. Date of Electronic Publication: 2024 Jul 31.
Autor:
Kayhanian H; UCL Cancer Institute, University College London, London, UK., Cross W; UCL Cancer Institute, University College London, London, UK.; Cancer Mechanisms and Biomarker Discovery Group, School of Life Sciences, University of Westminster, London, UK., van der Horst SEM; Oncode Institute, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands., Barmpoutis P; UCL Cancer Institute, University College London, London, UK.; UCL Centre for Medical Image Computing, Department of Computer Science, University College London, London, UK., Lakatos E; Department of Mathematical Sciences, Chalmers University of Technology and University of Gothenburg, Gothenburg, Sweden., Caravagna G; Department of Mathematics, Informatics and Geosciences, University of Trieste, Trieste, Italy., Zapata L; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK., Van Hoeck A; Oncode Institute, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands., Middelkamp S; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Litchfield K; UCL Cancer Institute, University College London, London, UK., Steele C; UCL Cancer Institute, University College London, London, UK., Waddingham W; UCL Cancer Institute, University College London, London, UK., Patel D; UCL Cancer Institute, University College London, London, UK., Milite S; Department of Mathematics, Informatics and Geosciences, University of Trieste, Trieste, Italy., Jin C; UCL Centre for Medical Image Computing, Department of Computer Science, University College London, London, UK., Baker AM; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK., Alexander DC; UCL Centre for Medical Image Computing, Department of Computer Science, University College London, London, UK., Khan K; Department of Oncology, UCL Cancer Institute, University College London, London, UK., Hochhauser D; UCL Cancer Institute, University College London, London, UK.; Department of Oncology, UCL Cancer Institute, University College London, London, UK., Novelli M; UCL Cancer Institute, University College London, London, UK.; Department of Pathology, University College London Hospital, London, UK., Werner B; Centre for Cancer Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, UK., van Boxtel R; Oncode Institute, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Hageman JH; Oncode Institute, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands., Buissant des Amorie JR; Oncode Institute, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands., Linares J; HSL-AD, London, UK., Ligtenberg MJL; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands., Nagtegaal ID; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Laclé MM; Department of Pathology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Moons LMG; Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht, The Netherlands., Brosens LAA; Department of Pathology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Pillay N; UCL Cancer Institute, University College London, London, UK., Sottoriva A; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Computational Biology Research Centre, Human Technopole, Milan, Italy., Graham TA; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Centre for Cancer Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, UK., Rodriguez-Justo M; UCL Cancer Institute, University College London, London, UK.; Department of Pathology, University College London Hospital, London, UK., Shiu KK; UCL Cancer Institute, University College London, London, UK.; Department of Oncology, UCL Cancer Institute, University College London, London, UK., Snippert HJG; Oncode Institute, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands. h.j.g.snippert@umcutrecht.nl., Jansen M; UCL Cancer Institute, University College London, London, UK. m.jansen@ucl.ac.uk.; Department of Pathology, University College London Hospital, London, UK. m.jansen@ucl.ac.uk.
Publikováno v:
Nature genetics [Nat Genet] 2024 Jul; Vol. 56 (7), pp. 1420-1433. Date of Electronic Publication: 2024 Jul 03.
Autor:
Challoner BR; The Institute of Cancer Research, London, UK., Woolston A; Barts Cancer Institute, Queen Mary University of London, London, UK., Lau D; The Royal Marsden NHS Foundation Trust, London, UK., Buzzetti M; Barts Cancer Institute, Queen Mary University of London, London, UK., Fong C; The Royal Marsden NHS Foundation Trust, London, UK., Barber LJ; Barts Cancer Institute, Queen Mary University of London, London, UK., Anandappa G; The Royal Marsden NHS Foundation Trust, London, UK., Crux R; The Royal Marsden NHS Foundation Trust, London, UK., Assiotis I; The Institute of Cancer Research, London, UK., Fenwick K; The Institute of Cancer Research, London, UK., Begum R; The Royal Marsden NHS Foundation Trust, London, UK., Begum D; The Institute of Cancer Research, London, UK.; The Royal Marsden NHS Foundation Trust, London, UK., Lund T; The Institute of Cancer Research, London, UK.; The Royal Marsden NHS Foundation Trust, London, UK., Sivamanoharan N; The Institute of Cancer Research, London, UK.; The Royal Marsden NHS Foundation Trust, London, UK., Sansano HB; The Royal Marsden NHS Foundation Trust, London, UK., Domingo-Arada M; The Royal Marsden NHS Foundation Trust, London, UK., Tran A; The Royal Marsden NHS Foundation Trust, London, UK., Pandha H; University of Surrey, Guildford, UK., Church D; Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Eccles B; University Hospitals Dorset NHS Foundation Trust, Bournemouth, UK., Ellis R; Royal Cornwall Hospitals NHS Trust, Truro, UK., Falk S; University Hospitals Bristol NHS Foundation Trust, Bristol, UK., Hill M; Maidstone and Tunbridge Wells NHS Trust, Maidstone, UK., Krell D; Royal Free London NHS Foundation Trust, London, UK., Murugaesu N; St George's University Hospitals NHS Foundation Trust, London, UK.; Genomics England, London, UK., Nolan L; Hampshire Hospitals NHS Foundation Trust, Winchester, UK., Potter V; University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK., Saunders M; The Christie NHS Foundation Trust, Manchester, UK., Shiu KK; University College London Hospitals NHS Foundation Trust, London, UK., Guettler S; The Institute of Cancer Research, London, UK., Alexander JL; Imperial College Healthcare NHS Trust, London, UK., Lázare-Iglesias H; University Clinical Hospital of Santiago de Compostela, Santiago de Compostela, Spain., Kinross J; Imperial College Healthcare NHS Trust, London, UK., Murphy J; Imperial College Healthcare NHS Trust, London, UK., von Loga K; The Institute of Cancer Research, London, UK.; The Royal Marsden NHS Foundation Trust, London, UK., Cunningham D; The Royal Marsden NHS Foundation Trust, London, UK., Chau I; The Royal Marsden NHS Foundation Trust, London, UK., Starling N; The Royal Marsden NHS Foundation Trust, London, UK., Ruiz-Bañobre J; University Clinical Hospital of Santiago de Compostela, Santiago de Compostela, Spain.; University of Santiago de Compostela, Santiago de Compostela, Spain., Dhillon T; Royal Surrey Hospital NHS Foundation Trust, Guildford, UK., Gerlinger M; Barts Cancer Institute, Queen Mary University of London, London, UK.; St Bartholomew's Hospital Cancer Centre, London, UK.
Publikováno v:
The Journal of pathology [J Pathol] 2024 Feb; Vol. 262 (2), pp. 226-239. Date of Electronic Publication: 2023 Nov 15.
Autor:
Mahmood U; Department of Gastrointestinal Oncology, University College Hospital NHS Foundation Trust (UCLH), London NW1 2BU, UK., Muhamad Faizul E; Faculty of Medical Sciences, University College London, London WC1E 6BT, UK., Howlett S; Department of Gastrointestinal Oncology, University College Hospital NHS Foundation Trust (UCLH), London NW1 2BU, UK., Amin Z; Department of Radiology, University College Hospital NHS Foundation Trust (UCLH), London NW1 2BU, UK., Hochhauser D; Department of Gastrointestinal Oncology, University College Hospital NHS Foundation Trust (UCLH), London NW1 2BU, UK.; University College London Cancer Institute, London WC1E 6DD, UK., Shiu KK; Department of Gastrointestinal Oncology, University College Hospital NHS Foundation Trust (UCLH), London NW1 2BU, UK.; University College London Cancer Institute, London WC1E 6DD, UK., Bridgewater J; Department of Gastrointestinal Oncology, University College Hospital NHS Foundation Trust (UCLH), London NW1 2BU, UK.; University College London Cancer Institute, London WC1E 6DD, UK., Khan K; Department of Gastrointestinal Oncology, University College Hospital NHS Foundation Trust (UCLH), London NW1 2BU, UK.; University College London Cancer Institute, London WC1E 6DD, UK.
Publikováno v:
Cancers [Cancers (Basel)] 2024 Feb 06; Vol. 16 (4). Date of Electronic Publication: 2024 Feb 06.
Autor:
Harvey S; University of Edinburgh, Cancer Research UK Edinburgh Centre, Institute of Genetics and Cancer, Western General Hospital, Edinburgh, UK., Stares M; University of Edinburgh, Cancer Research UK Edinburgh Centre, Institute of Genetics and Cancer, Western General Hospital, Edinburgh, UK.; Edinburgh Cancer Centre, NHS Lothian, Western General Hospital, Edinburgh, UK., Scott JA; Experimental Cancer Medicine Team (ECMT), The Christie NHS Foundation Trust, Manchester, UK., Thottiyil TJV; University College London Hospitals NHS Foundation Trust, London, UK., Conway AM; The University of Manchester, Cancer Research UK Manchester Institute, Manchester, UK.; The Christie NHS Foundation Trust, Manchester, UK., Haigh R; Edinburgh Cancer Centre, NHS Lothian, Western General Hospital, Edinburgh, UK., Brown J; Edinburgh Cancer Centre, NHS Lothian, Western General Hospital, Edinburgh, UK., Knowles G; Edinburgh Cancer Centre, NHS Lothian, Western General Hospital, Edinburgh, UK., Dasgupta S; Velindre University NHS Trust, Cardiff, UK., Shiu KK; University College London Hospitals NHS Foundation Trust, London, UK., Mitchell C; The Christie NHS Foundation Trust, Manchester, UK., Barrie C; Edinburgh Cancer Centre, NHS Lothian, Western General Hospital, Edinburgh, UK., Cook N; Experimental Cancer Medicine Team (ECMT), The Christie NHS Foundation Trust, Manchester, UK., Clive S; Edinburgh Cancer Centre, NHS Lothian, Western General Hospital, Edinburgh, UK.
Publikováno v:
Cancer medicine [Cancer Med] 2024 Feb; Vol. 13 (3), pp. e6988.
Autor:
Rha SY; Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea. Electronic address: rha7655@yuhs.ac., Oh DY; Cancer Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea., Yañez P; Department of Internal Medicine, James Lind Cancer Research Center, Universidad de La Frontera, Temuco, Chile., Bai Y; Department of Gastrointestinal Oncology, Harbin Medical University Cancer Hospital, Harbin, China., Ryu MH; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea., Lee J; Department of Medicine, Division of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University, Seoul, South Korea., Rivera F; Department of Medical Oncology, University Hospital Marqués de Valdecilla, IDIVAL, Santander, Spain., Alves GV; Centro Integrado de Pesquisa em Oncologia, Hospital Nossa Senhora da Conceição, Porto Alegre, Brazil., Garrido M; Department of Hemato-Oncology, Pontificia Universidad Católica de Chile, Santiago, Chile., Shiu KK; Gastrointestinal Oncology Service, University College London Hospitals, University College London Cancer Institute, NHS Foundation Trust, London, UK., Fernández MG; Hemato Oncólogo, IMAT-Oncomedica, Montería, Colombia., Li J; Department of Medical Oncology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China., Lowery MA; Department of Medical Oncology, Trinity St James Cancer Institute, Dublin, Ireland., Çil T; Department of Medical Oncology, Health and Science University, Adana City Hospital, Adana, Turkey., Cruz FM; Department of Medical Oncology, Instituto Brasileiro de Controle do Câncer, São Paulo, Brazil., Qin S; Department of Medical Oncology, Cancer Center of People's Liberation Army, Nanjing, China., Luo S; Department of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China., Pan H; Department of Medical Oncology, Zhejiang University School of Medicine, Sir Run Run Shaw Hospital, Hangzhou, China., Wainberg ZA; David Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Yin L; Biostatistics and Research Decision Sciences, Merck, Rahway, NJ, USA., Bordia S; Global Clinical Development, Merck, Rahway, NJ, USA., Bhagia P; Global Clinical Development, Merck, Rahway, NJ, USA., Wyrwicz LS; Department of Oncology and Radiotherapy, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2023 Nov; Vol. 24 (11), pp. 1181-1195. Date of Electronic Publication: 2023 Oct 21.